Rajendra Apte, MD
Enriched profilePaul A. Cibis Distinguished Professor of Ophthalmology and Visual Sciences; Vice Chair of Innovation and International Affairs/Translation · Washington University School of Medicine in St. Louis
Rajendra Apte is Paul A. Cibis Distinguished Professor of Ophthalmology and Visual Sciences; Vice Chair of Innovation and International Affairs/Translation at Washington University School of Medicine in St. Louis. OpenAlex indexes 244 publications with 13,333 citations (h-index 53); ClinicalTrials.gov lists 2 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Ophthalmology profiles in the findmyKOL directory.
Data verified 14 Aug 2026
Overview
Updated 27 Aug 2026
Rajendra Apte, MD, is Paul A. Cibis Distinguished Professor of Ophthalmology and Visual Sciences at Washington University School of Medicine in St. Louis, Department of Ophthalmology & Visual Sciences. The public record shows 244 publications with 13,333 citations (h-index 53), centered on Retinal Diseases and Treatments, Retinal Development and Disorders, Retinal and Optic Conditions. It also documents an investigator role on 2 registered clinical trials, industry payments reported by 6 companies, 4 NIH-funded awards (2005–2021).
- Most recent indexed publication: 2026 · Journal of vitreoretinal diseases
- Top research focus: Retinal Diseases and Treatments
- 2 registered trials on ClinicalTrials.gov
- Open Payments reporting from 6 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 20 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 124.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 2 registered studies on ClinicalTrials.gov. The most recent:
- SGLT2 Inhibitors in Geographic Atrophy
Sponsor: Washington University School of Medicine
- CAPTAIN:Choroidal Neovascularization Assessment by Pattern Electroretinography
Sponsor: Washington University School of Medicine
Industry payments
Updated 27 Aug 2026
6 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- F. Hoffmann-La Roche AGProgram year20256 payments$20,083openpaymentsdata.cms.gov ↗
- F. Hoffmann-La Roche AGProgram year20242 payments
- F. Hoffmann-La Roche AGProgram year20236 payments$17,655openpaymentsdata.cms.gov ↗
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
60.4%Vascular Endothelial Growth Factor Inhibitor60.4%Aflibercept100%Part B, office-administered≥39 patientsSensory organs
26.9%Corticosteroid12.5%Prednisolone Acetate100%Part D≥17 patientsCarbonic Anhydrase Inhibitor6.5%Dorzolamide-Timolol52%Dorzolamide Hcl48%Part D<11 patientsMusculoskeletal
8.9%Cyclooxygenase Inhibitor8.9%Ketorolac Tromethamine100%Part D≥13 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 27 Aug 2026
4 NIH research awards on record, funded 2005–2021 per NIH RePORTER. The latest:
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Clinical Outcomes and Predictors of Retinal Breaks in Patients With Vitreous Hemorrhage Secondary to a Posterior Vitreous Detachment.
Journal of vitreoretinal diseases
Article2026 - Energetic diversity in retinal ganglion cells is modulated by neuronal activity and correlates with resilience to degeneration.
Nature communications
Article2026
Most-cited works
by citation count (OpenAlex)Network
Updated 27 Aug 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/rajendra-apte-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
Mentions by others
where others cite or feature them- YouTube
youtube.com/watch
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- MD
L.T.M. Medical College, University of Bombay, India
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →ophthalmology.washington.edu ↗ - PhD in Cellular and Molecular Biology (Immunology)
University of Texas Southwestern Medical Center, Dallas
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →ophthalmology.washington.edu ↗ - Residency in Ophthalmology
UT Southwestern Medical Center / Parkland Hospital, Dallas
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →ophthalmology.washington.edu ↗ - Vitreoretinal Surgery Fellowship
Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →ophthalmology.washington.edu ↗ - Board Certified
American Board of Ophthalmology
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →health.usnews.com ↗
Editorial & leadership roles
journal and society appointments- Editorial Board Member
Ophthalmology Science (Elsevier)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →journals.elsevier.com ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.washu.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.washu.edu ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →ophthalmology.wustl.edu ↗
Secondary affiliations
appointments beyond the home institution- Professor
Department of Developmental Biology, Washington University School of Medicine
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →global.wustl.edu ↗ - McDonnell Scholars Academy member
Washington University in St. Louis
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →mcdonnell.washu.edu ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Ramaswamy Govindan, MD
Washington University School of Medicine in St. Louis
Marin Kollef, MD
Washington University School of Medicine in St. Louis
Mark Huffman, MD
Washington University School of Medicine in St. Louis
Brad Kahl, MD
Washington University School of Medicine in St. Louis